Malaria booster vaccine shows durable efficacy, study suggests

The research found that a vaccine booster dose one year after children received three doses as their primary vaccination regime maintained high efficacy against malaria.

Malaria booster vaccine shows durable efficacy, study suggests (Nick Potts/PA)

A malaria vaccine created by Oxford researchers “is really exciting” and could contribute towards drastically reducing the number of children who die from the infection, experts suggest.

A new study reports on the effectiveness of a malaria booster vaccine which shows long-lasting high efficacy in African children, meeting the World Health Organisation (WHO) specified 75% efficacy goal.